(Q50920500)

25 March 2018

title

Population pharmacokinetics of riluzole in patients with amyotrophic lateral sclerosis. (English)

1 reference

25 March 2018

amyotrophic lateral sclerosis

main subject

0 references

1 reference

Bruno R

1

1 reference

25 March 2018

Vivier N

2

1 reference

25 March 2018

Montay G

3

1 reference

25 March 2018

Le Liboux A

4

1 reference

25 March 2018

Powe LK

5

1 reference

25 March 2018

Delumeau JC

6

1 reference

25 March 2018

Rhodes GR

7

1 reference

25 March 2018

language of work or name

English

0 references

publication date

1 November 1997

1 reference

25 March 2018

Clinical Pharmacology & Therapeutics

published in

1 reference

25 March 2018

volume

62

1 reference

25 March 2018

issue

5

1 reference

25 March 2018

page(s)

518-526

1 reference

25 March 2018

Population pharmacokinetics

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990047-3

The population approach to pharmacokinetic data analysis: rationale and standard data analysis methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990047-3

Premarketing observational studies of population pharmacokinetics of new drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990047-3

An evaluation of population pharmacokinetics in therapeutic trials. Part I. Comparison of methodologies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990047-3

An evaluation of population pharmacokinetics in therapeutic trials. Part III. Prospective data collection versus retrospective data assembly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990047-3

Modelling of individual pharmacokinetics for computer-aided drug dosage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990047-3

Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990047-3

The clinical investigation of drugs for use by the elderly: Food and Drug guidelines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990047-3

Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990047-3

Designs for population pharmacodynamics: value of pharmacokinetic data and population analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990047-3

The importance of modeling interoccasion variability in population pharmacokinetic analyses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990047-3

Prediction of creatinine clearance from serum creatinine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990047-3

10.1016/S0009-9236(97)90047-3

7 January 2021

Identifiers

DOI

1 reference

25 March 2018

PubMed ID

9390108

1 reference

25 March 2018